Tin(II) oxalate

Genetic toxicity: in vitro

Administrative data

Endpoint:

in vitro cytogenicity / chromosome aberration study in mammalian cells

Remarks:

Type of genotoxicity: chromosome aberration

Type of information:

experimental study

Adequacy of study:

key study

Study period:

2011

Reliability:

1 (reliable without restriction)

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2012

Report date:

2012

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)

Deviations:

no

GLP compliance:

yes

Type of assay:

in vitro mammalian chromosome aberration test

Test material

Test material information

Constituent 1

Reference substance name:

stannous sulphate

IUPAC Name:

stannous sulphate

Method

Species / strain

Species / strain / cell type:

mammalian cell line, other: ncultured human peripheral blood lymphocytes

Additional strain / cell type characteristics:

other: female

Metabolic activation:

with and without

Metabolic activation system:

S9

Test concentrations with justification for top dose:

0.2500 - 300 µg/mL (> 40 different doses)

Controls

Controls 1

Untreated negative controls:

yes

Negative solvent / vehicle controls:

yes

True negative controls:

yes

Positive controls:

yes

Positive control substance:

4-nitroquinoline-N-oxide

Remarks:

without S9

Controls 2

Untreated negative controls:

yes

Negative solvent / vehicle controls:

yes

True negative controls:

yes

Positive controls:

yes

Positive control substance:

cyclohexylamine

Remarks:

with S9

Results and discussion

Test results

Test results 1

Species / strain:

mammalian cell line, other: cultured human peripheral blood lymphocytes

Metabolic activation:

with

Genotoxicity:

positive

Cytotoxicity / choice of top concentrations:

cytotoxicity

Vehicle controls validity:

valid

Untreated negative controls validity:

valid

Positive controls validity:

valid

Test results 2

Species / strain:

mammalian cell line, other: cultured human peripheral blood lymphocytes

Metabolic activation:

without

Genotoxicity:

ambiguous

Remarks:

negative for 3+17hr; positive for 20+0 hr

Cytotoxicity / choice of top concentrations:

cytotoxicity

Vehicle controls validity:

valid

Untreated negative controls validity:

valid

Positive controls validity:

valid

Remarks on result:

other: all strains/cell types tested

Remarks:

Migrated from field 'Test system'.

Any other information on results incl. tables

Stannous Sulfate, crystalline was tested in an in vitro cytogenetics assay using duplicate human lymphocyte cultures prepared from the pooled blood of three female donors in two independent experiments. Treatments covering a broad range of concentrations, separated by narrow intervals, were performed both in the absence and presence of metabolic activation (S-9) from Aroclor 1254 induced animals. The test article was formulated in water for irrigation (purified water). The highest concentrations used in the Main Experiments were limited by toxicity and were determined following preliminary cytotoxicity Range-Finder Experiments. Treatments were conducted (as detailed in the following summary tables) 48 hours following mitogen stimulation by phytohaemagglutinin (PHA). The test article concentrations for chromosome analysis were selected by evaluating the effect of Stannous Sulfate, crystalline on mitotic index. In each experiment, chromosome aberrations were analysed at three or four concentrations.

Appropriate negative (vehicle) control cultures were included in the test system in both experiments under each treatment condition. The proportion of cells with structural aberrations (excluding gaps) in these cultures fell within current historical vehicle control (normal) ranges. 4-Nitroquinoline 1-oxide (NQO) and cyclophosphamide (CPA) were employed as positive control chemicals in the absence and presence of rat liver S-9 respectively. Cells receiving these were sampled in each experiment, 20 hours after the start of treatment; both compounds induced statistically significant increases in the proportion of cells with structural aberrations. All acceptance criteria were considered met and the study was accepted as valid. Treatment of cells with Stannous Sulfate, crystalline for 3+17 hours in the absence of S-9 in Experiment 1 resulted in frequencies of cells with structural aberrations that were generally similar to those observed in concurrent vehicle control cultures. Numbers of aberrant cells (excluding gaps) fell within the 95th percentile of the observed range (0-3% aberrant cells) with the exception of one culture at the highest concentration analysed (5.000 μg/mL) in which 6% aberrant cells were observed, which fell outside the observed range of 0-4%. Treatment of cells for 20+0 hours in the absence of S-9 in Experiment 2 resulted in frequencies of cells with structural aberrations that were significantly higher (p ≤ 0.01) than those observed in concurrent vehicle control cultures at the highest two concentrations analysed (4.500 and 5.000 μg/mL, giving 42% and 57% mitotic inhibition, respectively). Numbers of aberrant cells (excluding gaps) exceeded the 95th percentile of the observed range in both cultures at 5.000 μg/mL and in single cultures at 4.000 and 4.500 μg/mL. The Experiment 2 data fulfilled the criteria for a positive result. Treatment of cells for 3+17 hours in the presence of S-9 in Experiment 1 resulted in frequencies of cells with structural aberrations that were slightly elevated, compared to those observed in concurrent vehicle control cultures, at all concentrations analysed. Numbers of aberrant cells (excluding gaps) exceeded the 95th percentile of the observed range (0-3% aberrant cells) in single cultures at all three concentrations analysed (7%, 6% and 5% at 80.00, 130.0 and 200.0 μg/mL, respectively). The aberrant cell frequencies (excluding gaps) in the replicate cultures at all three concentrations fell within the 95th percentile of the observed range, but the mean aberration frequencies exceeded the 95th percentile of the observed range at 80.00 and 200.0 μg/mL. These data were considered equivocal when viewed in isolation. Treatment of cells for 3+17 hours in the presence of S-9 in Experiment 2 resulted in frequencies of cells with structural aberrations that were significantly higher (p ≤ 0.001) than those observed in concurrent vehicle control cultures at the highest three concentrations analysed (100.0, 140.0 and 160.0 μg/mL, giving 39%, 53% and 57% mitotic inhibition, respectively). Numbers of aberrant cells (excluding gaps) exceeded the 95th percentile of the observed range in both cultures analysed at these concentrations. The Experiment 2 data fulfilled the criteria for a positive result, thus substantiating the result observed in Experiment 1 under this treatment condition. No increases in the frequency of cells with numerical aberrations, which exceeded the concurrent controls and the normal ranges, were observed in cultures treated with Stannous Sulfate, crystalline in the absence and presence of S-9 in Experiments 1 and 2. It is concluded that Stannous Sulfate, crystalline induced structural chromosome aberrations in cultured human lymphocyte cells when tested for 3+17 hours in the presence of S-9 and for 20+0 hours in the absence of S-9. In the same test system, Stannous Sulfate, crystalline did not induce structural chromosome aberrations when tested up to toxic concentrations for 3+17 hours in the absence of S-9..

Applicant's summary and conclusion

Conclusions:

Interpretation of results (migrated information):
positive with metabolic activation
ambiguous without metabolic activation negative for 3+17hr; positive for 20+0 hr

It is concluded that Stannous Sulfate, crystalline induced structural chromosome aberrations in cultured human lymphocyte cells when tested for 3+17 hours in the presence of S-9 and for 20+0 hours in the absence of S-9. In the same test system, Stannous Sulfate, crystalline did not induce structural chromosome aberrations when tested up to toxic concentrations for 3+17 hours in the absence of S-9.